sirt1-null mice develop an autoimmune-like condition
- Center for Cancer Therapeutics, Ottawa Health Research Institute, Box 926, 3rd Floor, 501 Smyth Road, Ottawa, Ontario, K1H 8L6 (Canada)
- Center for Kidney Research, Ottawa Health Research Institute, Ottawa (Canada)
- Department of Cellular and Molecular Medicine, University of Ottawa (Canada)
- Department of Pathology and Laboratory Medicine, University of Ottawa (Canada)
The sirt1 gene encodes a protein deacetylase with a broad spectrum of reported substrates. Mice carrying null alleles for sirt1 are viable on outbred genetic backgrounds so we have examined them in detail to identify the biological processes that are dependent on SIRT1. Sera from adult sirt1-null mice contain antibodies that react with nuclear antigens and immune complexes become deposited in the livers and kidneys of these animals. Some of the sirt1-null animals develop a disease resembling diabetes insipidus when they approach 2 years of age although the relationship to the autoimmunity remains unclear. We interpret these observations as consistent with a role for SIRT1 in sustaining normal immune function and in this way delaying the onset of autoimmune disease.
- OSTI ID:
- 21128162
- Journal Information:
- Experimental Cell Research, Vol. 314, Issue 16; Other Information: DOI: 10.1016/j.yexcr.2008.07.011; PII: S0014-4827(08)00275-9; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
- Country of Publication:
- United States
- Language:
- English
Similar Records
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype
Mercury and autoimmunity: implications for occupational and environmental health